Fast Tracks and Roadblocks for Zika Vaccines
AbstractIn early 2014, a relatively obscure virus, the Zika virus, made headlines worldwide following an increase in the number of congenital malformations. Since then, research on Zika virus, treatment and vaccines have progressed swiftly with various drugs being repurposed and vaccines heading into clinical trials. Nonetheless, the need for a vaccine is crucial in order to eradicate this re-emerging arthropod-borne virus which remained silent since its first discovery in 1947. In this review, we focused on how the inconspicuous virus managed to spread, the key immunological factors required for a vaccine and the various vaccine platforms that are currently being studied. View Full-Text
Share & Cite This Article
Ghaffar, K.A.; Ng, L.F.; Renia, L. Fast Tracks and Roadblocks for Zika Vaccines. Vaccines 2018, 6, 77.
Ghaffar KA, Ng LF, Renia L. Fast Tracks and Roadblocks for Zika Vaccines. Vaccines. 2018; 6(4):77.Chicago/Turabian Style
Ghaffar, Khairunnisa A.; Ng, Lisa F.; Renia, Laurent. 2018. "Fast Tracks and Roadblocks for Zika Vaccines." Vaccines 6, no. 4: 77.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.